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ABSTRACT 
A naturally-occurring 2.2kb defective interfering (DI) RNA of bovine coronavirus 
(BCo V) has been cloned and is being used as a minireplicon to characterize the cis-acting 
elements in its structure for DI RNA replication. The DI RNA is comprised of the two 
ends of the virus genome, the 5 '-most 498-nt and the 3 '-1803-nt including a poly(A) tail 
of 68-nt, and it replicates in the presence of the parent helpervirus. Within the DI RNA is 
a single open reading frame (ORF) resulting from the fusion of 288-nt of gene 1 a and the 
entire 1348-nt N gene. A 30-nt in-frame reporter has been inserted at base position 1098 
to enable quantitative Northern analyses of DI RNA replication. The hypothesis that cis­
acting elements for replication lie within the 288-nt partial ORF 1 a region was suggested 
by (1) the presence of a similar region in all coronavirus DI RNAs described to date, and 
(2) a previous experiment which showed that DI RNA replication was blocked by 
conversion of the ORF 1 a start codon to a non-start codon. To test this hypothesis, the 
study described here was undertaken to map and characterize the cis-acting element( s) 
within the partial ORF l a  region. For this, 5 prime-ward in-frame deletions of the 288-nt 
gene 1 a region were made from its 3' terminus and transcripts were tested for replication. 
It was learned that 3 '-terminal, in-frame deletions of 102 nt ( encoding aa 63-96) but not 
141 nt (encoding aa 50-96), were tolerated for DI RNA replication. Further analysis of 
the remaining 186-nt revealed the presence of two cis-acting elements. The first is a 
protein encoded by the ORF. This was learned from frameshift experiments that changed 
the identity of 12 and 26 amino acid stretches, respectively, while maintaining a fused 
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ORF. These changes resulted in the loss of DI RNA replication. The second cis-acting 
element is a higher-order RNA structure. This was learned by testing a phylogenetically­
conserved, computer (mfo/d)-predicted 36-nt RNA stem-loop located between nt 308 and 
343. Mutations predicted to disrupt the stem while maintaining the wild-type amino acid 
sequence destroyed replicating ability whereas compensatory mutations restoring the 
secondary structure also restored replicating ability. This study is the first to identify cis­
acting elements for coronavirus RNA replication mapping within the ORF 1 a region of 
the genome. It is also the first study to show any function for coronavirus gene 1 a. It is 
predicted that the cis-acting elements identified here for DI RNA replication will have the 
same function in the full-length bovine coronavirus genome. 
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CHAPTER I. 
LITERATURE REVIEW ON C/S-ACTING SIGNALS IN BOVINE 
CORONA VIRUS DEFECTIVE INTERFERING RNA REPLICATION 
INTRODUCTION 
Bovine coronavirus (BCo V) is an enveloped, positive-sense, single-stranded, 
RNA virus with a genome length of 31, 030 bases (Nixon and Brian, unpublished). As 
with other positive-strand RNA viruses, BCo V is believed to replicate in membrane­
associated replication complexes (Dennis and Brian, 1982; Brayton et al., 1984; Tung et 
al., 1992; Sethna and Brian, 1997; Sims et al., 2000; Bost et al., 2001). Members of the 
family Coronaviridae in the order Nidovirales possess the largest known RNA genomes. 
In addition to size, another defining characteristic of Coronaviruses is a unique 
transcription strategy in which an identical 5 '-leader sequence of approximately 65 nts, 
encoded only at the 5'-terminus of the genome, is placed onto the 5'-end of each species 
of a 3 '-coterminal, nested set of subgenomic (sg) mRNAs (BCo V generates seven sg 
mRNAs ). The largest mRNA is identical to the genome and the smallest is less than 2 kb 
in length. The mRNAs function monocistronically as only the 5 '-most open reading 
frame (ORF) in each case is translated to give rise to viral structural or nonstructural 
proteins. Translation of the genome must occur before RNA synthesis can begin. ORF 
la and lb overlap to comprise approximately two-thirds of the coronavirus genome and 
this region encodes the enzymes responsible for RNA replication. ORF 1 a is translated 
as a single polyprotein of approximately 500 kDa which is then proteolytically processed 
by viral-encoded proteinases. Translation of ORF lb gives rise to a polyprotein of 
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approximately 800 kDa via ribosomal frameshifting at a slippery sequence and 
pseudoknot located at the overlap region between ORF la and lb. It is also 
proteolytically processed to produce proteins that include the RNA-dependent RNA 
polymerase and helicase required for RNA synthesis (Lai and Cavanagh, 1997); (Brierley 
et al., 1987), an estimated 16 functional proteins in all based on predicted protease 
cleavage sites. 
Although full-length cDNA clones have recently been obtained for transmissible 
gastroenteritis virus (Almazan et al., 2000; Yount et al., 2000) and human coronavirus 
229E (Thiel et al., 2001), a full-length cDNA clone does not yet exist for BCoV. 
Therefore, insight into the cis-acting signals responsible for BCo V genome replication is 
attainable at this time only through studies on defective interfering (DI) RNA 
minireplicons. A minireplicon of the 2.2kb, naturally-occurring BCoV DI RNA, named 
pDrep 1, has been obtained in our laboratory and is being used to investigate the cis­
acting signals required for its replication (Fig.1-1) (Chang et al., 1994). This study 
examines specifically the cis-acting elements residing within the 288-nt partial ORF 1 a 
region of the BCoV DI RNA. The partial ORF la region is the 5'-most portion of the DI 
RNA-encoded ORF, and it is fused in-frame to the full-length N gene. Interestingly, all 
coronavirus DI RNAs described to date encode some portion of the 5'-end of ORF la 
(Brian and Spaan, 1997). To date, no cis-acting replication elements have been described 
within ORF 1 a. 
BACKGROUND ON BCoV DI RNA REPLICATION 
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Figure 1-1. Schematic depiction of the BCo V genome and sub genome-size 
molecules used to study RNA replication. A. DI RNA is the naturally-occurring 2,133 
nt-long BCo V defective-interfering RNA that is intermediate in size between mRNA 
7( encoding the N protein) and mRNA 6 ( encoding the M protein). pDrep 1 is the cloned 
DI RNA with an in-frame 30-nt reporter sequence cloned into the Bgffi site and used for 
quantitative Northern analyses in replication studies. Depicted is the T7-polymerase­
generated transcript of pDrep 1. pNrep2 is a clone of mRNA 7 containing the same 30-nt 
reporter as pDrep 1. Transcripts of pNrep2, which do not replicate after transfection into 
helper virus-infected cells, differ from transcripts of pDrep 1, which do replicate, by 421 
nts (Chang et al., 1994). The 5'-tenninal 65 nt leader is depicted as a filled rectangle. B. 
Schematic depiction of the 421-nt difference between replicating pDrep 1 and 
nonreplicating pNrep2. 
3 
Historically, defective RNA (D RNA) and defective interfering RNA (DI RNA) replicons 
have been the experimental workhorses for identifying cis-acting replication elements in 
RNA viruses (Holland, 1985). D RNA and DI RNA are extensively deleted derivatives of 
the full-length virus genome. D RNAs and DI RNAs arise in nature as the result of 
replicase error in which the RNA-dependant RNA polymerase (RdRp) jumps from one 
RNA template to another, possibly during RNA replication or nonhomologous 
recombination {Lai and Cavanagh, 1997; Furuya et al., 1993; Lai, 1992). The resulting 
replicons usually lack an independent ability to replicate since all or some of the RdRp is 
commonly missing and must, therefore, be co-infected with helper virus to have access to 
the missing genomic functions. Additionally, DI RNA "interferes" with the replication of 
helper virus, whereas D RNA does not. The trans-acting RdRp is usually, but not 
always, the helper component supplied by the helper virus (Holland, 1985). Since D 
RNA and DI RNA genomes are minireplicons, cis-acting elements required for 
replication and packaging must be present within their sequence. 
Currently known cis-acting requirements for BCo V DI RNA. 
Previous work by Chang et al. (1994) led to the cloning of pDrepl. To create 
pDrepl, a 30-nt reporter sequence was inserted at the BgilI site within the N gene at DI 
RNA nt position 1098. This insert has been extensively used for the quantitation of 
pDrep 1 plus and minus-strand molecules by Northern analysis in replication assays 
(Chang et al., 1994; Chang et al., 1996; Chang and Brian, 1996; Krishnan, R. et al., 
1996; Ozdarendeli, A. et al., 2001 ). pDrep 1 is 2.2kb in length and contains the genomic 
210-nt 5'-UTR (that includes the 65-nt genomic leader), the 288-nt 5'-terminal portion of 
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gene l a  fused in-frame to the 1348-nt full-length N gene, a 288-nt 3'-UTR, and a 68-nt 
poly(A) tail. When in vitro-synthesized transcripts of pDrep 1 are transfected into helper­
virus infected cells, plus-strand accumulation, indicative of DI RNA replication, is 
measured by Northern analysis. Packaging and passaging of progeny of pDrep 1 with the 
helper virus are also observed and routinely monitored. 
Much work has been done to determine the cis-acting elements required for 
BCoV DI RNA replication. With the use ofpDrepl ,  cis-acting signals that have been 
identified to date include the genomic leader sequence, RNA stem loops I, II, III, and IV 
all within the 210-nt 5'-UTR, a translational requirement for the DI RNA-encoded fusion 
ORF, the N protein sequence, an RNA pseudoknot within the 3'-UTR and a poly(A) tail. 
Enzyme structure probing of the RNA secondary structure suggested that the leader 
contains all of stem loop I and part of stem-loop II as predicted by computer-assisted 
RNA foldings (Chang et al., 1994). Mutagenesis of leader sequence within stems I and II 
resulted in rapid reversion of leader to wild-type sequence (Chang et al., 1994; Chang et 
al., 1996). Further downstream within the 210-nt 5 '-UTR are computer (mfold)-predicted 
stem-loop III and stem-loop IV, located at nts 85 to 128 and nts 186 to 215, respectively. 
Enzyme structure probing has verified the existence of each of these and mutagenesis 
studies have revealed that maintenance of both is required for DI RNA replication 
(Raman, unpublished). Preliminary gel shift assays, furthermore, revealed that cellular 
and/or viral proteins bind these structures (Raman, unpublished). Within the 3 '-UTR is a 
pseudoknot structure proposed to function either as a translational enhancer or as an 
element binding proteins in the formation of a replication complex (Williams et al., 
1999). The 3 '-terminal poly(A) tail has also been implicated as a cis-acting element for 
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DI RNA replication (Senanayake, unpublished; Spagnolo and Hogue, 2000). The 
poly(A) tail is hypothesized to function by binding the cellular poly(A) binding protein 
and facilitating translation through a circularization mechanism (Spagnolo and Hogue, 
2000). In addition, it was learned that the single, continuous la-N ORF present in BCoV 
DI RNA must remain open and translatable for replication (Chang and Brian, 1996). 
Premature translation termination resulting from frameshift mutations led to loss of DI 
RNA replication. Additionally, the N protein sequence appeared to be a cis-acting 
element. 3 '-terminal N gene sequence truncations of greater than 15% were not tolerated 
for DI RNA replication, nor was substitution of N by a naturally occurring I protein ORF 
(occurring within N gene sequence but in an alternate reading frame). The exogenous 
CAT gene could also not be substituted for N (Chang and Brian, 1996). 
Rationale for the study of the 288-nt ORF la region in DI RNA replication. 
Three observations led us to seek the identity of cis-acting elements within the 
ORF l a  region. (1) This region of ORF la is present in all coronavirus DI RNAs 
described to date (reviewed in Brian and Spaan, 1997). (2) Stop codons preventing 
translation of the partial ORF 1 a region also prevented DI RNA replication (Chang and 
Brian, 1996). (3) BCoV subgenomic mRNA 7 postulated to be a replicon (Sethna et al., 
1989), but missing 133-nt of the genomic 5'-UTR and the 288-nt ORF la region, failed 
to replicate following transfection into helper virus infected cells (Fig.1-1; Chang et al., 
1994). 
The 288-nt ORF la region encodes the first 96 aa ofp28 (280 aa total), the 5'­
most cleavage product of ORF 1 a as described for mouse hepatitis coronavirus (Denison 
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and Perlman, 1986; Dong et al., 1995). This cleavage site appears nearly identical in 
BCo V (Nixon and Brian, unpublished). While the function of MHV p28 remains 
unknown, biochemical evidence of its localization by cell fractionation shows 
co fractionation of p28 with newly synthesized RNA suggesting it may have a role in 
RN A synthesis or in formation or maintenance of membranous replication complexes 
(Sims et al., 2000). RNA synthesis in membranous replication complexes is well 
documented in plus-stranded RNA viruses (Dennis and Brian, 1982; Brayton et al., 1984; 
Tung et al., 1992; Sethna and Brian, 1997; Hansen et al., 1998; Shi et al., 1999; Denison 
et al. 1999; van der Meer et al., 1999; Sims et al., 2000; Bost et al., 2001). These 
observations further suggest a role for the complete p28 or a portion of it. 
The 288-nt partial ORF la region has not been examined as a potential site for 
cis-acting elements for RNA replication. Therefore, the following questions are addressed 
in this chapter. Is the partial ORF la region required in cis for DI RNA replication in 
BCo V? If so, might it function to provide a cis-acting protein product, or the presence of 
cis-acting higher-order RNA structural elements, or both? 
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CHAPTER II. 
TRANSLATION OF THE PARTIAL ORF lA REGION IS A C/S-ACTING 
REQUIREMENT FOR DEFECTIVE-INTERFERING RNA REPLICATION IN 
BOVINE CORONA VIRUS 
INTRODUCTION 
Translation of the virus genome is a required first step in the replication of all 
plus-strand RNA viruses. This is necessary since the viral RdRp is not a structural 
component of the virus and needs to be generated for genome replication. In addition to 
this requirement, however, there has also been found, for a number of plus-strand viruses, 
a curious cis-acting requirement for translation in genome replication. Translation as a 
cis-acting requirement for replication has been shown experimentally for defective RNA 
(D RNA) replication ofpoliovirus (Novak and Kirkegaard, 1994), turnip yellow mosaic 
virus (TYMV) (Weiland and Dreher, 1993), mouse hepatitis coronavirus A59 (MHV­
A59) (de Groot et al., 1992) and BCoV (Chang and Brian, 1996) and more recently in 
Kunjin virus (Khromykh et al., 1999). Required translation of portions of D RNA are 
postulated to be due to cis-action of a protein product or due to required ribosomal 
passage in cis (Novak and Kirkegaard, 1994). 
By using poliovirus helper virus and poliovirus defective RNAs in an amber 
codon suppressing cell line in comparison with a nonsuppressing cell line it was 
demonstrated that important regions like the 3Dpol can be complemented in trans. 
However, translation of the cis required region, a region that remains to have its borders 
determined, must occur in cis. While the mechanism for translation as a cis-requirement 
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for RNA replication remains unknown, it has been shown not to be due to an influence on 
RNA stability or on a constant supply of viral proteins to nascent RNA strands (Novak 
and Kirkegaard, 1994). 
The requirement for translation in cis has also been found for the Kunjin virus ns5 
gene. The C-terminal region of the ns5 gene product contains several conserved RdRp 
motifs of various postulated functions (O'Reilly et al., 1998; Khromykh, et al., 1999), 
while the N-terminal region contains two conserved methyltransferase domains (Koonin, 
1993; Khromykh, et al., 1999). Complementation analysis with this flavivirus showed 
that the 3 '-terminal half of the NS5 coding region of a defective RNA could be 
effectively complemented in trans, and RNA replication was rescued in persistently 
infected cells. However, frameshift mutations at the beginning ofNS5 and deletions into 
the 5 '-terminal half of the NS5 coding region resulted in loss of replication due to 
inability ofN-terminal NS5 to be trans-complemented. These results suggested that only 
when the N-terminus ofNS5 is translated in cis can RNA be recognized and efficiently 
amplified (Khromykh et al., 1999). 
The requirement for translation in cis has been found in turnip yellow mosaic 
virus for which there is a concurrent processing of the 206-kDa protein into p70 and p150 
(Weiland and Dreher, 1993). These proteins contain the RdRp and helicase motifs, 
respectively. Translation in cis in this virus is thought to aid in the assembly of 
replication proteins preferentially and efficiently into a replication initiation complex on 
that same RNA molecule. Channeling cis-acting proteins for function on same RNA 
molecules for complex formation is predicted to aid the switch between 
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mRNA/translation role to template role for minus strand synthesis (Weiland and Dreher, 
1993). 
Dependence on translation in cis for replication of coronavirus DI RNAs has been 
observed, but the degree of dependence is not the same for all molecules. For DI MIDI 
and DISSE ofMHV, for example, dependence on translation in cis is not strict, and these 
molecules are characterized as having a preference for translation in cis (Kim et al., 
1993). That is, molecules without a contiguous open reading frame will replicate, but 
lose out over time to replicons that gain a contiguous open reading frame. By contrast, 
the DI RNA isolated from BCoV in our studies as characterized by the pDrepl construct 
has a strict requirement for the contiguous open reading frame extending throughout 
approximately 70% of the N portion of the contgious ORF (Chang and Brian, 1996). 
Blockage by insertion of termination codons within the partial ORF 1 a or N ORF 
anywhere within the first 70% of the N sequence, kills replication (Chang and Brian, 
1996). Moreover, the quality of the N gene product appears to be important since a frame 
shifting mutation leading to the expression of I in place ofN does not support replication. 
Thus, for the BCoV DI RNA there is a strict requirement for translation in cis for 
replication. 
A preliminary study has suggested that in BCo V pDrep 1 the ORF 1 a region may 
require translation in cis for replication (Chang and Brian, 1996). Conceptually, this is an 
important issue since BCo V mRNAs, postulated to be replicons (Sethna et al., 1989), fail 
to replicate (Chang et al., 1994). Cloned BCoV mRNA 7 (pNrep2) is identical to pDrepl 
except for 421-nt of contiguous 5 '  proximal sequence (Fig.1-1 ). The partial ORF 1 a 
region is contained within the 421-nt sequence. To investigate the cis-acting elements 
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associated with the ORF l a  requirement for DI RNA replication, two sets of experiments 
were performed. First, a construct was synthesized in which the partial ORF 1 a region 
was precisely deleted while the full-length 210-nt 5'-UTR and full-length N gene were 
maintained. Second, mutations introducing stop codons at various internal locations 
throughout the ORF 1 a sequence were made in order to prematurely terminate 
translation. Both sets of constructs were tested for DI RNA replication in the in vivo 
replication assay. Loss of replication in both sets of experiments suggested that the 
process of translation for ORF 1 a is, indeed, required in cis for BCo V DI RNA 
replication. To determine if the quality of the ORF l a  gene product is also required, two 
frameshift constructs were generated that created different amino acid sequences for 
stretches of 12 and 26 amino acids, and these were tested in the in vivo replication assay. 
The results indicate that the quality of the partial ORF 1 a gene product is a cis-acting 
requirement for BCo V DI RNA replication. 
MATERIALS AND METHODS 
Virus and cells. 
Bovine coronavirus Mebus strain was plaque-purified three times and used as 
helper virus in all replication experiments. Stock preparations had an infectious titer of 1 
x 107 PFU/ml. Human rectal tumor cell line, HRT-18, was used in all experiments. Cells 
were grown as monolayers in Dulbecco' s modified Eagle medium containing 10% fetal 
calf serum (Atlanta Biological, Atlanta, GA) in 35 mm2 plates. 
1 1  




Using the indicated DNA template and respective oligonucleotides designated 
below and in Table 2-1, the following constructs were made via overlap PCR 
mutagenesis, followed by recombination PCR. All PCR mutagenesis reactions were 
performed under the same conditions: lX Pfu Turbo enzyme buffer, 0.2mM dNTPs, 25ng 
of respective DNA template, 0.5µM of each of respective primer (+) and primer (-) and 
l.25U (0.5µ1) Pfu Turbo enzyme (Stratagene), plus water for a final volume of 50µ1. 
Initial denaturation was performed at 94° C for 2 minutes. Denaturation, annealing and 
extension conditions were 94 ° C, 55 ° C, and 72 ° C, respectively. All temperatures were 
maintained for 1 minute each for a total of 13 cycles. Final renaturation was performed 
at 72 ° C for 10 minutes. 
Recombination PCR was performed using the two products generated during PCR 
mutagenesis. In preparation for recombination PCR, PCR products were either excised 
from a T AE gel and genecleaned or directly removed via pipette from the TBE gel. For 
maximal DNA production, due to a need for further molecular manipulations after 
recombination PCR, 3-4 50-µ1 (total 150-200 µI) recombination reactions were prepared. 
Denaturation, annealing, and extension temperatures were 94 ° C, 60 ° C, and 72 ° C, 
respectively, for 2 minutes each in 17 total cycles. Final renaturation was performed at 
72 ° C for 10 minutes. 
12  
Plasmid constructs were all modifications of pDrep 1 (Chang and Brian, 1996) 
except as noted. For each, mutated regions were confirmed by sequencing at the UTK 
Molecular Biology Resource Facility. 
p77Drep 1 was generated by PCR overlap mutagenesis. For this, the gel-purified 
1197-nucleotide (nt) PCR product from a pDrepl-templated reaction with primers 
PGEM3Zf(-) 2097 and 77LDI(+) and the gel-purified 782-nt PCR product from a 
reaction with D1211-232(-) and oligo 2(+) were created. Recombination PCR with 
PGEM3Z( -) 2097 and oligo 2( +) formed a 2095-nt product, from which the 115 8-nt Ndel 
fragment was used to replace the analogous region in pDrep 1. 
p210Nrep was created by digesting pNrep2 (Chang et al. , 1994) with Bg/11, 
creating a 754-nt fragment and replacing the analogous region in Bg/11- digested pDrepl. 
Similarly, p226AAA ➔ UAA was generated by PCR overlap mutagenesis using 
the 957-nt fragment from a reaction with primer PGEM3Z 2477(-) and laSTOP226(+) 
and the 777-nt fragment from a reaction with primers 1 aSTOP226(-) and oligo 2( + ). 
Recombination PCR with PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt fragment, 
of which the 443-nt Hpal-Xbal fragment was used to replace the analogous region in 
pDrepl. 
p268AUG➔UGA was synthesized identically to pla226AAA➔UAA except 
PCR overlap mutagenesis replaced primers laSTOP226(+) and laSTOP226(-) with 
laSTOP268( +) and 1 aSTOP268(-), respectively. 
p211AUG➔UGA was generated by PCR overlap mutagenesis using the 941-nt 
fragment from a reaction with primers PGEM3Z 2477(-) and 5'STOP(+) and the 793-nt 
fragment from a reaction with 5'STOP(-) and oligo 2(+). Recombination PCR with 
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PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt product of which the 443-nt Hpal­
Xbal fragment was used to replace the analogous region in pDrep 1. 
p468AUA ➔ AM was synthesized by linearizing plasmid DNA with Ndel. Two 
nucleotides were deleted by mung bean nuclease digestion and religated. 
pFS@223 was generated by two rounds of PCR overlap mutagenesis first using 
the 957-nt fragment from a reaction with primers FS@223(+) and PGEM3Z 2477(-) and 
the778-nt fragment from FS@223(-) and oligo 2( + ). Recombinant PCR with PGEM3Z 
2477(-) and oligo 2(+) yielded a 1715-nt fragment from which the 1158-nt Ndel fragment 
was used to replace the analogous region in pDrep 1. A second round of PCR 
mutagenesis using the above pFS@223 plasmid as template restored the proper reading 
frame by recombining the 1039-nt IF@304(+) and PGEM3Z 2477(-) and the 699-nt 
IF@304(-) and oligo 2(+) fragments. The 1716-nt recombinant product yielded a 1158-
nt fragment after Ndel digestion that was used to replace the analogous region in 
pFS@223. 
pFS@270was generated in an identical manner using reactions with primers 
FS@270(+) with PGEM3Z 2477(-) and FS@270(-) with oligo 2(+). The corresponding 
products1003-nt and 732-nt were used in recombination PCR with PGEM3Z 2477(-) and 
oligo 2(+). 
In vitro transcription. 
Transcription of plasmid constructs including p211AUG➔UGA, 
p211AUG➔ UUG, p226AAA ➔ UAA, p268AUG➔ UGA, and p468AUA ➔ AM was 
performed using T7 RNA polymerase as recommended by Promega. For this, 1 0µg of 
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Mlul linearized plasmid DNA was blunt-ended with mung-bean nuclease and 5µg of 
linearized, blunt-ended DNA was transcribed with 40 units (U) ofT7 RNA polymerase 
(Promega, Madison, WI) in a 100µ1 reaction which included supplied transcription 
buffer, lOµg bovine serum albumin (BSA), lOmM DTT, lO0U RNasin and rNTPs. The 
transcription reaction mix was then treated with SU ofRNase-free DNase (Promega, 
Madison, WI) and newly synthesized RNA was chromatographed through a Biospin 6 
column (Bio-Rad, Melville, NY) and quantitated by spectroscopy. 
Assay for replication: transfection and Northern blot analysis. 
HRT cells grown to 50-80% confluency (~106 cells) in 35 mm2 dishes were 
infected with BCV at a multiplicity of 10 PFU per cell by incubating cells with the 
inoculum at 37° C plus 5% CO2 for lh. Cells were refed with 2ml Dulbecco's modified 
Eagle's medium containing 10% fetal bovine serum and incubated at 37° C plus 5% CO2 
for 1-1.Sh. 
For transfection, each plate of cells was rinsed three times with lX phosphate­
buffered saline (PBS). Cells were treated for 10 min at room temperature with 1 0µg 
Lipofectin (Invitrogen Gibco-BRL, Carlsbad, CA), lµg transcript and varying amounts of 
IX PBS to make a total volume of 200µ1. Cells were rinsed with 2ml of growth medium 
without fetal bovine serum. Cells were then incubated at 37° C with 2ml Dulbecco's 
modified Eagle medium containing 10% fetal bovine serum until cytoplasmic RNA 
extraction was performed at 1 h, 24 h, and 48 h post transfection (hpt). 
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For serial passage of progeny virus, cell supernatant was harvested at 48 h post 
infection and 500µ1 was used to directly infect cells at 50-80% confluency in 35-mm2 
dishes. Cytoplasmic RNA was extracted at 48 hours post infection for analysis. 
For cell harvest and RNA extraction, cells were washed three times with Earle's 
balanced salt solution at the designated time points. With cells on ice, 500µ1 of lysis 
buffer (lOmM Tris buffer, lOmM NaCl, 5mM MgCh , and 1 % NP40) were added to each 
plate. Cell debris was pelleted at 9400 rpm for 4 min at 4° C and the remaining RNA in 
aqueous solution was treated with proteinase K for 30 minutes at 37° C. After phenol­
chloroform extraction, RNA was precipitated from the aqueous phase by adding two 
volumes of absolute ethanol. Precipitated RNA was stored at -20 ° C. 
One 35-mm dish yielded approximately lOµg of RNA. For Northern analysis, 
2.5µg of RNA was loaded per well in a 1 % formaldehyde-containing, agarose gel. RNA 
samples for electrophoresis were prepared by pelleting precipitate from 500µ1 of the 
RNA-ethanol suspension. The RNA pellet was resuspended in a sample mixture 
composed of 1.9µ1 lOX morpholinopropane sulfonic acid (MOPS) buffer, 3.3µ1 37% 
formaldehyde, 9.3µ1 100% foramide, and water. Loading buffer was added after samples 
were heated for 10 min at 65° C. lng of transcript for each construct was prepared and 
loaded as a size marker. The gel was loaded, covered in a lX MOPS-formaldehyde 
buffer, and electrophoresed at 150 V for 3.5-4.5 h. 32P-radiolabeled nucleotide probes 
were prepared as described (Sethna et al. 1989). The specific activities of the probes 
ranged from lx106 to 4x107 cpm/pmole and film exposure times ranged from 24 hours to 
7 days. 
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Electrophoresed RNA was blotted onto nylon membrane (Amersham Biosciences, 
Piscataway, NJ) by vacuum transfer in 20X SSC buffer. After a 3h transfer, RNA was 
crosslinked on the �embrane by ultraviolet radiation. The membrane was prehybridized 
in 10ml prehybridization buffer for 6+ h at 55° C in a rotisserie oven. 32P-end labeled 
oligonucleotide TGEV 8 (+) was used as the probe for Northern analysis (Hofmann et al. , 
1990). The membranes were washed in 2X SSC containing 10% SDS for 20 min at room 
temperature and 25 min at 55° C before drying and exposure to film. 
Reverse transcription PCR and sequencing to identify revertant molecules. 
The construct p211AUG➔ UUG was cDNA cloned using oligonucleotide TGEV 
#8b for reverse transcription. Then, single-stranded cDNA was amplified by using 
primers TGEV #8( +) and leader (-). Gel-purified products were sequenced at the UTK 
Molecular Biology Resource Facility. 
In vitro translation. 
In vitro translation of transcripts were performed in wheat germ lysate and rabbit 
reticulocyte lysate, as specified by the manufacturer (Promega, Madison, WI). For 
translation in the wheat germ extract, 50µ1 reactions containing 1 00U RNasin, 1.17mM 
potassium acetate, 0.02 mM amino acid solution minus methionine, lmCi/ml of 35 S 
methionine (ICN), 0.3 to lµg RNA transcript, and 25µ1 wheat germ extract were used. 
Incubation was at 25° C for 1 h. 
For translation in rabbit reticulocyte lysate, 50µ1 reactions containing 35µ1 of 
nuclease-treated rabbit reticulocyte lysate, l00U RNasin, 0.02 mM amino acid mixture 
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minus methionine, 0.3 to lµg RNA transcript, and lmCi/ml of 35 S methionine were 
used. Incubations were at 30° C for 1 h. Both wheat germ and rabbit reticulocyte 
reactions were stopped by the addition of an equal volume of 2X Laemmli standard 
treatment buffer (STB) (lX STB contains 0.0625M Tris buffer, pH 6.5, 2% SDS, 10% 
glycerol and 1 0µg bromophenol blue). Products were analyzed on an 8% SDS­
polyacrylimide gel according to the procedure ofLaemmli (1970). 
Synthetic oligonucleotides. 
Oligonucleotides used in this study are described in Table 2-1. Oligonucleotides 
were synthesized by Sigma-Genosys {The Woodlands, TX) or Invitrogen Gibco-BRL 
(Carlsbad, CA). 
RESULTS 
Both the 210-nt genomic 5'-UTR and the 288-nt partial ORF la regions harbor cis­
acting elements for BCo V DI RNA replication. 
To test whether the 288-nt partial ORF 1 a region harbors cis-acting elements for 
DI RNA replication, two constructs were generated. The first, called p77Drep, was 
identical to the replicating pDrepl (Fig. 1-1) except that the 210-nt genomic 5'-UTR in 
pDreplwas replaced with the 77-nt 5'-UTR from mRNA 7. The second, called 
p210Nrep2, was identical to pNrep2 (Fig. 1-1) except that the 77-nt 5'-UTR was replaced 
with the 210-nt genomic 5 '-UTR. These constructs are illustrated in Fig. 2-1. 
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Table 2-1. Oligonucleotides used in this study. 
Oligonucleotide• Sequence6· c Binding region (nt position,3 
FS@223(+) GACCGTATTTCT�rCATCCTCG 215-235 
FS@223(-) CGAAGATC�CAAATACGGTC 215-235 
FS@270(+) GCGTCCTC�cTCCATGG 262-281 
FS@270(-) CCATGGATdoTTGAGGACGC 262-281 
IF@304(+) CCTCTGAACTACTGAGGGTTATC 295-316 
IF@304(-) OAT AACCCTCAGTAGTTCAGAGG 295-316 
laSTOP270(+) CCTCAAACTACCATGGAAATTC 256-277 
laSTOP270(-) GAATTTCCATGGTAGTTTGAGG 256-277 
laSTOP226(+) GACCGTATTAGTTGATCTTC 216-235 
laSTOP226(-) GAAGATCAACTAATACGGTC 216-235 
5'STOP(-) CATAGGTCACATAGTCGAAGATC 200-222 
5 'STOP(+) GATCTTCGAI.QTGACCTATG 200-219 
DM(+) GTTGATCTTCGACAATGTGACC 204-225 
DM(-) GGTCACAITGTCGAAGATCAA 204-225 
77LDI(+) GAGCGATTTGCGTGCGTGCATCCCGC 7-32 
D1211-232(-) CGTATTTGTTGATCTTCGACAT/CCTTAAAGTTTAG 65-74/211-232 
PGEM3Z 2097(-) AGGGCGACACGGAAATGTTG 2097-2116 
PGEM3Z 2477(-) GGCATCAGAGCAGATTGTACTG 2477-2498 
Oligo 2(+) GTCCCGATCGAGAATGTCAGCCGGGG 968-993 
Leader (-) GAGCGATTTGCGTGCGTGCATCCCGC 7-32 
TGEV#8(+) CATGGCACCATCCTTGGCAACCCAGA 1098-1123 
TGEV#8bt!:l CATGGCACCATCCTTGGCA 1105-1123 
a Oligonucleotide binds to either plus-sense RNA, as indicated by (+), or to minus-sense RNA, as indicated by (-). 
b Underlined bases indicate differences from genomic sequence. 
c Bold type bases indicate additional bases added to genomic sequence. 
dNumbers correspond to pDrepl + strand sequence, except for TGEV#8 and #Sb(+), in which cases numbers refer to the TGEV N gene 
plus-strand sequence (Kapke and Brian, 1986) .  Oligonucleotide numbers in PGEM3Z2477(-) corresponds to plasmid vector sequence. 
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Figure 2- 1 .  Schematic depiction of defective-interfering constructs used to test the cis-requirements for the 
genomic 5'-UTR and the partial ORF l a  region. A. Evidenced by Northern assay that pDrepl replicates in 
helper virus-infected cells whereas pNrep2 does not (*from Chang et al., 1 994). B.  p77Drep, containing the 77-
nt 5'-UTR present on pNrep2 and the 288-nt ORF l a  region fused to full-length N gene, does not replicate in 
helper virus-infected cells. Likewise, p210Nrep containing the 2 10-nt genomic 5 '-UTR but lacking the 288-nt 
partial ORF l a  region does not replicate. 
To create p77Drep, the 210-nt, 5'UTR of pDrep was precisely replaced with the 77-nt, 
5'-UTR of the mRNA N message via recombinant PCR mutagenesis. The ORF la-N 
gene fusion remained intact. A replication assay was performed in which human rectal 
tumor (HRT} cells were first infected with BCoV helper virus, transfected with mutant 
p77Drep transcript, and RNA was extracted at designated time points. p77Drep 
transcript was visible only at 1 hour posttransfection (hpt) by Northern analysis and no DI 
RNA was visible at 24 and 48 hpt indicating that no replication had taken place (Fig. 2-
1 ). Passaging of DI RNA mutants with progeny virus was monitored by infecting fresh 
HRT cells with the infectious supernatant from 48 hpt and probing for DI RNA in the 
replication assay. No DI RNA accumulation was observed at viral passage 1 indicating 
that no replicon had been packaged and passaged along with progeny virus. Since the 
removal of the 210-nt 5'-UTR resulted in the loss of DI RNA replication in p77Drep, it 
was concluded that cis-acting signals are present in the unique 133-nt of the UTR. 
Analysis of these cis-acting elements is being further analyzed by S. Raman (Raman, 
unpublished results). 
To test if the 288-nt partial ORF la region contains cis-acting elements for DI 
RNA replication, p21 ON rep was created. PCR mutagenesis was performed in which the 
entire 288-nt of the partial ORF la region was removed, leaving the full-length 210-nt, 
5 '-UTR fused to the full-length N gene. In this, a known cis-acting element, stem loop 
IV, mapping between nts 186 and 215 that includes the AUG start codon at base 211, was 
fully restored based on M-fold predictions. This happened since the first 5-nt of the N 
gene correspond identically to the first 5-nt of the partial ORF la region. When HRT 
cells were infected with BCoV and transfected with p210Nrep transcripts in a replication 
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assay, no evidence for DI RNA replication was observed at 24 or 48 hpt. Also, no 
packaged DI RNA was observed at viral passage 1. From these results, it was concluded 
that the 288-nt partial ORF la region contains cis-acting elements for BCoV DI RNA 
replication. 
Premature termination of partial ORF la translation resulted in loss of BCoV DI 
RNA replication. 
To test whether translation of the entire 288-nt ORF 1 a region is required for 
BCoV DI RNA replication, individual stop codons were placed throughout the partial 
ORF la region and tested. In construct p211AUG➔UGA, a UGA stop codon was 
introduced at the start codon site (base 211) of the partial ORF la region (Fig. 2-2) by 
PCR mutagenesis. At 1 hpt in the replication assay, p211AUG➔UGA transcript was 
detected by Northern analysis, but at 24 and 48 hpt RNA was undetectable indicating 
little or no replication had taken place. No DI RNA was detected at viral passage 1 and 
only extremely low amounts were detected at viral passage 2 leading to the conclusion 
that DI RNA replication had been severely impaired when a stop (UGA) codon replaced 
the start codon of the partial ORF la domain. 
In construct p211AUG➔UUG the start codon of the partial ORF la region was 
mutated to a leucine (UUG) codon (Fig. 2-2). While the transcript of p211AUG➔ UUG 
was clearly visible at 1 hpt, only a slight amount was observed at 24 hpt and no band was 
visible at 48 hpt. No DI RNA was detected at viral passages 1 and 2. A repeat of the 
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Figure 2-2. Non-start codon insertions and effects on RNA replication. A. Schematic 
depiction of RNA sequence in the 288-nt partial ORF la region, showing stem-loops 
IV (Raman, unpublished) and VII. Potential stem-loops V and VI are not depicted 
here. B. Non-start codon insertion sites in the partial ORF 1 a region and affects on 
replication as assayed by Northern analysis. 
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virus passage 1 after long exposure to film. Reverse transcription-PCR and DNA 
sequencing analysis on RNA extracted from virus passage 1 showed that the UUG 
mutation had not been maintained. The DI RNA visible in the faint band at viral passage 
1 was, in fact, a revertant containing the wild-type AUG start codon. It was therefore 
concluded that a mutation of the partial ORF la start codon to UUG, even though a non­
stop codon, caused significantly impaired replication of DI RNA. 
Likewise, severe impairment ofDI RNA replication was observed in mutant' 
p226AAA ➔ UAA, in which the lysine (AAA) codon, located 15 nt into the open reading 
frame, was mutated to a UAA stop codon and in construct p268AUG➔ UGA in which an 
internal methionine AUG codon, located 78 nt into the parital ORF 1 a open region, was 
replaced with a UGA stop codon (Fig. 2-2). 
In construct, p468AUA➔AM, a 2-nt deletion created at the Bg!II site at nt 468 
resulted in a frameshift that created a U AA stop codon at nt 4 71 which was also lethal for 
replication (Fig. 2-2). 
Thus, the observed loss of DI RNA replication by the insertion of stop codons at 
nt 211, 226, 268,and 471 led to the conclusion that there is a cis-acting requirement of 
translation for BCo V DI RNA replication. It is not clear from these experiments whether 
the requirement is for the synthesis of a cis-acting protein or for the mere act of 
translation itself. 
In vitro translation assays verify premature termination of translation in mutant 
BCo V DI RNA constructs. 
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To verify that the stop codons created in p211AUG➔UGA, p211AUG➔UUG, 
p225AAA ➔ UAA, p268AUG➔ UGA and p468AUA ➔ AM lead to premature 
termination of translation, in vitro translation reactions were performed with the 
transcripts of each mutant in both wheat germ and rabbit reticulocyte lysates and the sizes 
of the products were determined. Previous work by R.Y. Chang (1996) had demonstrated 
that translation of the N gene was a cis-acting requirement for BCoV DI RNA 
replication. In vitro translation of wild-type pDrep in rabbit reticulocyte lysate revealed 
two major translation products, one of approximately 66kDa corresponding in size to the 
pDrep-encoded partial ORF la-N gene fusion protein and one of approximately 50 kDa 
corresponding in size to the N protein alone. Three additional minor products were 
observed that migrated between the two major bands ( data not shown). It is possible that 
these represent products of translation initiating at AUG positions 268, 385, and 454. 
This would happen if ribosomes had scanned through the start codon at 211. Similar in 
vitro translation results for pDrep were observed in reactions performed in wheat germ 
lysate ( data not shown). 
As expected, no full size ORF la-N fusion translation product was observed from 
in vitro translation of p268AUG➔ UGA in rabbit reticulocyte lysate, although a product 
the size of N alone was found indicating a potential scanning to the start site ofN. 
Interestingly, three additional bands indicating potential translation starting from one of 
three non-start methionines within the internal coding region of partial ORF 1 a were 
found ( data not shown). 
In in vitro translation in rabbit reticulocyte lysate ofp211AUG➔UUG revealed a 
minor translation product which could have resulted from the use ofUUG as a weak start 
25 
codon. The ability ofUUG to serve as a weak start codon has been observed (Donahue 
and Cigan, 1988; Coleman and Raetz, 1988; Coderre and Earhart, 1989; Mauch et al., 
1990; Lahue and Matson, 1990; Yoon and Donahue, 1992; Tolner et al., 1995; Sussman 
et al., 1996; Thurlow et al., 1997; Huang et al. , 1997; Yeh et al. , 1997; Ghrist and 
Stauffer, 1998; Hirose et al. , 1999; Nett et al. ,  2001). Curiously, in this construct the N 
protein alone became the most abundant translation product. In vitro translation in wheat 
germ lysate showed similar results. Also, for reasons we cannot explain, in vitro 
translation of p211AUG➔ UGA which should not have allowed ribosomal translation to 
commence at start codon nt 211, did show abundant quantities of the full length ORF 1 a­
N fusion protein ( data not shown). 
Since N protein synthesis in vitro as evidenced by strong bands of the appropriate 
size remains efficient in all mutants, it would seem that any cis-acting requirement for N 
should be fulfilled ifN protein synthesis from these constructs is efficient in vivo as well. 
It is clear, however, that these mutants do not replicate, and this leads us to conclude that 
some aspect of ORF 1 a translation or the ORF 1 a translation product is required for 
BCo V DI RNA replication. 
Frameshift mutation analyses within the partial ORF 1 a region suggest a cis-acting 
role for the ORF la polypeptide in BCoV DI RNA replication. 
In an attempt to answer whether the cis-acting translation requirement of the ORF 
1 a region is due to the process of translation or to a specific protein product, two 
frameshift mutant constructs were generated and tested. In construct pFS@223, a 
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frameshift was created by deleting the adenosine at nt position 223 such that a sequence 
of 27 amino acids would be changed (Fig. 2-3). In order to maintain the required open 
reading frame, a cytosine was inserted by PCR mutagenesis at nt position 304. The 
identities of26 of27 of the original amino acids (amino acids 5 to 31) were changed by 
this frameshift. In the replication assay, there was no evidence that transcripts of 
pFS@223 underwent replication by 24 or 48 hpt, or at virus passages 1 or 2 (Fig. 2-3). 
In the second construct, pFS@270, a single guanosine was deleted by PCR 
mutagenesis at nt position 270 and a cytosine was inserted at nt position 304 resulting in 
a change in the identity of a 12 amino acid stretch (aa 20 to 31) (Fig. 2-3). As with 
pFS@223, the frameshift in pFS@270 resulted in a lethal mutation. 
The results with the two frameshift constructs suggest that the polypeptide 
product of the partial ORF la is necesssary for BCoV DI RNA replication. It cannot be 
rigorously ruled out at this time, however, that the frameshifting mutations did not alter a 
cis-acting RNA structural requirement for replication. Although mfold analyses predict 
that there had been no alteration of higher-order RNA structures by these mutations, 
subtle higher-order structure changes or even changes in a necessary primary nucleic acid 
structure might have taken place. Further testing will be required to rigorously establish 
that a cis-acting polypeptide element is important for BCoV DI RNA replication 
( discussed further in Chapter N). 
DISCUSSION 
In experiments presented here it was documented that translation of the 288-nt 
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Figure 2-3 . Amino acid sequences and replication (by Northern assay) analyses of frame shift 




along with an earlier demonstration that translation of some portion of N gene sequence 
is also required for replication (Chang and Brian, 1996), brings to two the number of 
elements requiring translation in cis for replication in the BCoV DI RNA. The cis 
requirement for partial ORF 1 a translation was determined by three experimental 
approaches. First, precise removal of the 288-nt partial ORF 1 a region resulted in loss of 
DI RNA replication. Second, insertion of stop codons throughout the partial ORF la 
region leading to premature termination of translation resulted in loss of DI RNA 
replication. In vitro translations in both rabbit reticulocyte lysate and wheat germ 
verified that premature termination of translation takes place with these constructs. 
Third, frameshift mutations that maintained the full length of the fused ORF 
demonstrated that the quality of the ORF la product is important for DI RNA replication. 
Frameshift experiments that altered 12 or 26 of the 96 total amino acids generated by the 
partial ORF la region resulted in complete loss of DI RNA replication. 
The requirement for translation of the partial ORF 1 a region could be two-fold. 
One, translation might be required for synthesis of a cis-acting protein. Loss of DI RNA 
replication in two frameshift mutants suggests that some quality in cis of the encoded 
partial ORF 1 a polypeptide is required for maintaining replication. A second possibility 
is that the process of translation, or of ribosomal passage, somehow is a prerequisite for 
assembly of the RNA replication complex. These possibilities have been suggested by 
Novak and Kirkegaard (1994) in reference to poliovirus replication for which a similar 
cis-acting dependence on translation had been found. 
The fact that the partial ORF la sequence needs to be translated in cis for DI RNA 
replication leads to two broad categories of questions regarding mechanism. 1) The first 
29 
is a set of questions addressing how the cis-translation event functions in the DI RNA. 
Given that the DI RNA is an artifactual molecule, that is, it is a fusion product of the two 
ends of the large coronavirus genome, the mechanism of how cis-translation pertains to. 
ORF 1 a may not be directly applicable to the genome. On the other hand, it might serve 
the same function in the genome but has undergone adaptation for the DI RNA. We view 
the fusion event creating the DI RNA a fortuitous one and that the cis-requirement for 
ORF la translation probably functions similarly in the full-length, multi-cistronic 
genome. 
With regard to the first set of questions, namely, how does a cis-requirement for 
ORF la translation function in DI RNA replication, the simplest model that would seem 
to apply in one articulated in various forms by those who have studied viruses ( and their 
cognate D RN As) that contain only a single open reading frame. That is, the protein made 
in cis is presented locally, thus, facilitating assembly of the replication complex. Using 
deletion analysis, Novak and Kirkegaard (1994) identified a region of the poliovirus 
genome requiring cis translation. A newly synthesized, cis-acting protein was postulated 
to interact with the mRNA to identify the template for negative strand synthesis. Perhaps 
the cis-acting protein has a strong affinity for its mRNA template, thereby, keeping the 
protein localized. Also, if protein stability were limited, cis action by the protein might 
be predicted to preferentially occur only with the template from which it was synthesized 
(Novak and Kirkegaard, 1994). 
Like picomaviruses, Kunjin virus (flavivirus) RNA is translated as a single ORF. 
Deletion mutations demonstrated that parts of ns5 sequence could not be complemented 
in trans. Kunjin virus requires translation in cis of its N terminal ns5 coding sequence for 
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replication. The cis-acting NSS protein was hypothesized to interact with other 
nonstructural proteins to initiate formation of the replication complex for negative strand 
synthesis (Khromykh et al., 1999). 
As with BCo V DI RNA, all four clover yellow mosaic virus (CYMV) D RNA 
species were found to consist of an in-frame fusion of the N terminus of ORF 1, the 
putative replicase, and the C terminus of the coat protein ORF 5 to form a fused single 
ORF. CYMV D RNA accumulation in vivo requires translation of the fusion protein. 
Small, in-frame deletions and insertions in the coat protein gene in this case, however, 
did not affect D RNA replication suggesting the encoded fusion polypeptide sequence is 
insignificant in the replication process (White et al., 1992). 
With regard to the second set of questions, namely, how would cis-acting 
translation for ORF la function in a multicistronic genome, an explanation might reside 
in a circular model for the genome. Conceivably, any of the 16 proteolytically-derived 
ORF 1 proteins could remain localized with the genome during translation of ORF 1. It 
has been widely postulated that replication of plus-strand RNA genomes may require 
circularization of the genome through 3' and 5' interactions. If circularization takes 
place, then the products of ORF 1 could be localized near the 3 '-terminus (the starting 
point for minus-strand synthesis and the site for assembly of the RNA replication 
complex) soon after synthesis. IfN is required in the replication complex after being 
synthesized in cis, conceivably, it could be made by an internal ribosomal entry onto the 
N ORF (suggested by Chang and Brian, 1996). 
Certainly, not all coronavirus DI RNAs exhibit the same degree of dependence on 
the cis-acting requirement for translation . For MHV DI RNAs, for example, a 
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contiguous ORF within the DI RNA is not a strict requirement for replication, but rather, 
there is a "preference" for the ORF in cis. This could mean that the partial ORF 1 a 
product may more easily reach the replication complex, or possibly the equivalent 
molecule encoded by the viral genome may function in trans. Some large coronavirus DI 
RNAs, for example those from TGEV and IBV, are multicistronic and, perhaps, the ORF 




A HIGHER-ORDER CIS-ACTING RNA ELEMENT WITHIN THE PARTIAL 
ORF IA REGION AS A REQUIREMENT FOR DEFECTIVE-INTERFERING 
RNA REPLICATION IN BOVINE CORONA VIRUS 
INTRODUCTION 
The 5 'and 3' untranslated regions on the genomes of plus-strand RNA viruses 
were once believed to contain all of the necessary cis-acting signals for genome 
replication. Recently, it has been discovered that for some viruses, RNA elements within 
the internal coding regions are also required in cis for replication (McKnight and Lemon, 
1998; Lobert et al., 1999; Goodfellow et al. , 2000; Barrera et al., 1993; Miranda et al. , 
1997). Thus, these RNA elements have a dual function, (1) to encode a protein and (2) to 
directly participate as a signal for genome replication. Three genera in the family 
Picomaviridae, the rhinoviruses, cardioviruses, and enteroviruses, contain a cis-acting 
replication element (ere) at various positions in the protein coding region. In each case, 
these elements are higher order RNA structures that fit the definition of a stem-loop. The 
first internal ere discovered was in human rhinovirus type 14 (HR V-14) (McKnight and 
Lemon, 1996). The HRV-14 ere is a 96-nt stem-loop structure located in the VPl  coding 
sequence (McKnight and Lemon, 1998). With the use of dicistronic constructs, the 
investigators were able to dissociate RNA replication from translation and to demonstrate 
both the replication and coding functions of this RNA element. Additionally, mutational 
analysis demonstrated that the structure functions in the positive strand and not in the 
negative strand (McKnight and Lemon, 1998). 
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The second and third internal cres to be identified were in Theiler's virus and 
mengo virus, both cardioviruses (Lobert et al., 1999). The RNA secondary structure 
present in a 130-nt stretch of the VP2 capsid protein structurally resembled the HRV-14 
ere but differed in location. A functional exchange of this nt stretch could be made 
between Theiler's and mengo viruses. However, exchanges of the HRV-14 ere between 
those were not tolerated (Lobert et al., 1999). Site-directed mutagenesis of a conserved 
9-nt region in cardioviruses revealed that each nt was important for function in the ere. 
Additionally, mutations destabilizing the base paired stem region resulted in loss of 
replication whereas a compensatory mutation restoring the stem structure restored wild­
type replication (Lobert et al., 1999). 
In 2000, a ere mapping within the poliovirus 2C coding region and showing 
conservation with a ere in enteroviruses was discovered. This internal ere was 61-nt in 
length and contained highly conserved sequences in the base paired stem region but 
varied considerably in the loop sequence. Interestingly, addition of a second ere structure 
to a mutant containing a disabled ere resulted in restored replication (Goodfellow et al, 
2000). 
While the locations within the genome and the sizes of the respective cres of 
poliovirus and HRV-14 differ, there are several notable similarities. (1) Both ere 
structures function in the positive or genome-sense strand. (2) Both structures have an 
apparent role in minus strand initiation. (3) Neither structure is position-dependent 
within the context of the coding region of the genome (McKnight and Lemon, 1998; 
Goodfellow et al. 2000). 
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To investigate the possibility that the predicted higher-order RNA structures 
mapping within the 288-nt ORF 1 a region are cis-acting replication elements ( cres) for 
DI RNA replicatio�. two sets of experiments were done. First, a series of 3 '-terminal, in­
frame deletions within the partial ORF 1 a region were constructed to determine what 
sequences and thus what potential stem-loops were required for DI RNA replication. 
Second, mutagenic analyses were done on the phylogenetically-conserved stem-loop VI 
which mapped within the active region of the partial ORF 1 a sequence and, thus, showed 
a high potential for being a cis-acting element for replication. For this, site-directed 
mutagenesis disrupting base pairing of the stem portion was carried out in ways that did 
not disrupt the amino acid sequence. Disrupted and restored stems were analyzed for 
replication. Both sets of experiments support the notion that stem-loop VI mapping 
between nts 308 and 343 is a ere, very similar in function to the cres described in 
picomavirus genomes. This is the first report of a ere in coronavirus mapping within a 
protein-coding region. 
MATERIALS AND METHODS 
Virus and cells. 
Bovine coronavirus Mebus strain was plaque-purified three times and used as 
helper virus in all replication experiments. Stock preparations had an infectious titer of 1 
x 107 PFU/ml. The human rectal tumor cell line, HRT-18, was used in all experiments. 
Cells were grown as monolayers in Dulbecco's modified Eagle medium containing 10% 
fetal calf serum (Atlanta Biological, Atlanta, GA) in 35 mm2 plates. 
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Construction of plasmids. 
Using the indicated DNA template and respective oligonucleotides designated 
below and in Table 3-1, the following constructs were made via overlap PCR 
mutagenesis, followed by recombination PCR. All PCR mutagenesis reactions were 
performed under the same conditions: lX Pfu Turbo enzyme buffer, 0.2mM dNTPs, 25ng 
of respective DNA template, 0.5µM of each of respective primer (+) and primer (-) and 
l .25U (0.5µ1) Pfu Turbo enzyme (Stratagene ), plus water for a final volume of 50µ1. 
Initial denaturation was performed at 94° C for 2 minutes. Denaturation, annealing and 
extension conditions were 94 ° C, 55 ° C, and 72 ° C, respectively. All temperatures were 
maintained for 1 minute each for a total of 13 cycles. Final renaturation was performed 
at 72 ° C for 10 minutes. 
Recombination PCR was performed using the two products generated during PCR 
mutagenesis. In preparation for recombination PCR, PCR products were either excised 
from a TAE gel and genecleaned or directly removed via pipette from the TBE gel. For 
maximal DNA production, du_e to a need for further molecular manipulations after 
recombination PCR, 3-4 50-µl (total 150-200 µ1) recombination reactions were prepared. 
Denaturation, annealing, and extension temperatures were 94 ° C, 60 ° C, and 72 ° C, 
respectively, for 2 minutes each in 17 total cycles. Final renaturation was performed at 
72 ° C for 10 minutes. 
Plasmid constructs were all modifications of pDrep 1 (Chang and Brian, 1996) 
except as noted. For each, mutated regions were confirmed by sequencing at the UTK 
Molecular Biology Resource Facility. 
36 
The 3' deletion constructs were all made by overlap PCR mutagenesis with the 
same three primers and one differing mutant oligo. Nstart(-) and oligo 2(+) yielded a 
494-nt product. PGEM3Z 2477(-) and varying mutant primers produced PCR products 
of various sizes. Recombination PCR with PGEM3Z 2477(-) and oligo 2(+) resulted in 
a product of varying sizes according to mutant primer used, of which the Hpal-Xbal 
fragment was used to replace the analogous region in pDrepl. p1�478-498 used the 
mutant primer 1�478-498(+) and yielded an Hpal-Xbal fragment of 423-nt. p1�454-
498 used the mutant primer 1�454-498(+) and yielded an Hpal-Xbal fragment of 399-
nt. p1�442-498 used the mutant primer 1�442-498(+) and yielded an Hpal-Xbal 
fragment of 387-nt. p1�424-498 used the mutant primer 1�423-498(+) and yielded an 
Hpal-Xbal fragment of369-nt. p1�397-498 used the mutant primer 1�397-498(+) 
and yielded an Hpal-Xbal fragment of342-nt. p1�358-498 used the mutant primer 
1�358-498(+) and yielded an Hpal-Xbal fragment of302-nt. p1�319-498 used the 
mutant primer 1�319-498(+) and yielded an Hpal-Xbal fragment of264-nt. p1�283-
498 used the mutant primer lru\283-498(+) and yielded an Hpal-Xbal fragment of228-
nt. p1�38-498 used the mutant primer lru\238-498(+) and yielded an Hpal-Xbal 
fragment of 183-nt. pl�l 7-498 used the mutant primer 1�17-498(+) and yielded an 
Hpal-Xbal fragment of 162-nt. 
pLeft VI was generated by PCR overlap mutagenesis using the 1051-nt fragment 
from a reaction with primers PGEM3Z 2477(-) and Left vi(+) and the 688-nt fragment 
from a PCR reaction with Left vi(+) and oligo 2(+). Recombination PCR with PGEM3Z 
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2477(-) and oligo 2(+) yielded a 1765-nt product of which the 1158-nt Ndel fragment was 
used to replace the analogous region in pDrepl. 
pRight VI was generated by PCR overlap mutagenesis using the 1065-nt fragment 
from a reaction with primers PGEM3Z 2477(-) and Right vi(+) and the 674-nt fragment 
from a PCR reaction with Right vi(+) and oligo 2( + ). Recombination PCR with 
PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt product of which the 1158-nt Ndel 
fragment was used to replace the analogous region in pDrepl. 
pLtRt VI was generated in an identical manner to construct pLeft VI except that 
pRight VI was used as the template in PCR reactions, not pDrep 1. 
In vitro transcription. 
Transcription of plasmid constructs including plaL\217-498, plaL\238-498, 
plaL\283-498, plaL\319-498, plaL\358-498, plaL\397-498, plaL\424-498, plaL\442-498, 
p 1 aL\454-498, p 1aL\478-498, pLeft VI, pRight VI, and pLtRt VI was performed using T7 
RNA polymerase as recommended by Promega. For this, 1 0µg of Mlul linearized 
plasmid DNA was blunt-ended with mung-bean nuclease, and 5 µg of linearized, blunt­
ended DNA was transcribed with 40 units (U) of T7 RNA polymerase (Promega, 
Madison, WI) in a 100µ1 reaction which included supplied transcription buffer, 1 0µg 
bovine serum albumin (BSA), 1 OmM DTT, 1 00U RNasin and rNTPs. The transcription 
reaction mix was then treated with 5U ofRNase-free DNase (Promega, Madison, WI) 
and newly synthesized RNA was chromatographed through a Biospin 6 column (Bio­
Rad, Melville, NY) and quantitated by spectroscopy. 
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Assay for replication: transfection and Northern blot analysis. 
HRT cells grown to 50-80% confluency (~106 cells) in 35 mm2 dishes were 
infected with BCV at a multiplicity of 10 PFU per cell by incubating cells with the 
inoculum at 37° C plus 5% _CO2 for lh. Cells were refed with 2ml Dulbecco's modified 
Eagle's medium containing 10% fetal bovine serum and incubated at 37° C plus 5% CO2 
for 1-l .5h. 
For transfection, each plate of cells was rinsed three times with lX phosphate­
buffered saline (PBS). Cells were treated for 10 min at room temperature with 1 0µg 
Lipofectin (Invitrogen Gibco-BRL, Carlsbad, CA), l µg transcript and varying amounts of 
lX  PBS to make a total volume of 200µ1. Cells were rinsed with 2ml of growth medium 
without fetal bovine serum. Cells were then incubated at 37° C with 2ml Dulbecco's 
modified Eagle medium containing 10% fetal bovine serum until cytoplasmic RNA 
extraction was performed at 1 h, 24 h, and 48 h post transfection (hpt). 
For serial passage of progeny virus, cell supernatant was harvested at 48 h post 
infection and 500µ1 was used to directly infect cells at 50-80% confluency in 35-mm2 
dishes. Cytoplasmic RNA was extracted at 48 hours post infection for analysis. 
For cell harvest and RNA extraction, cells were washed three times with Earle's 
balanced salt solution at the designated time points. With cells on ice, 500µ1 of lysis 
buffer (1  OmM Tris buffer, 1 OmM NaCl, 5mM MgCh , and 1 % NP40) were added to each 
plate. Cell debris was pelleted at 9400 rpm for 4 min at 4° C and the remaining RNA in 
aqueous solution was treated with proteinase K for 30 minutes at 37° C. After phenol­
chloroform extraction, RNA was precipitated from the aqueous phase by adding two 
volumes of absolute ethanol. Precipitated RNA was stored at -20 ° C. 
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One 35-mm dish yielded approximately lOµg of RNA. For Northern analysis, 
2.5 µg of RNA was loaded per well in a 1 % formaldehyde-containing, agarose gel. RNA 
samples for electrophoresis were prepared by pelleting precipitate from 500µ1 of the 
RNA-ethanol suspension. The RNA pellet was resuspended in a sample mixture 
composed of 1.9µ1 lOX morpholinopropane sulfonic acid (MOPS) buffer, 3.3µ1 37% 
formaldehyde, 9.3µ1 100% foramide, and water. Loading buffer was added after samples 
were heated for 10 min at 65° C. lng of transcript for each construct was prepared and 
loaded as a size marker. The gel was loaded, covered in a lX MOPS-formaldehyde 
buffer, and electrophoresed at 150 V for 3.5-4.5 h. 32P-radiolabeled nucleotide probes 
were prepared as described (Sethna et al. 1989). The specific activities of the probes 
ranged from lx106 to 4x107 cpm/pmole and film exposure times ranged from 24 hours to 
7 days. 
Electrophoresed RNA was blotted onto nylon membrane (Amersham Biosciences, 
Piscataway, NJ) by vacuum transfer in 20X SSC buffer. After a 3h transfer, RNA was 
crosslinked on the membrane by ultraviolet radiation. The membrane was prehybridized 
in 10ml prehybridization buffer for 6+ h at 55° C in a rotisserie oven. 32P-end labeled 
oligonucleotide TGEV 8 (+) was used as the probe for Northern analysis (Hofmann et al., 
1990). The membranes were washed in 2X SSC containing 10% SDS for 20 min at room 
temperature and 25 min at 55° C before drying and exposure to film. 
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Synthetic oligonucleotides. 
Oligonucleotides used in this study are described in Table 3-1. Oligonucleotides 
were synthesized by Sigma-Genosys {The Woodlands, TX) or Invitrogen Gibco-BRL 
(Carlsbad, CA). 
RNA secondary structure modeling. 
Computer-assisted RNA secondary structure modeling was performed using 
mfold version 3. 1 at http://bioinfo.math.mi.edu/-mfold/ma/forml .cgi (Zuker et al. , 1999; 
Mathews et al. , 1999). 
RESULTS 
Deletion of 102-nt, but not 141-nt, from the 3'-terminus of the 288-nt ORF la region 
is tolerated for DI RNA replication. 
It has been previously shown that the 288-nt ORF la region of cloned BCoV DI 
RNA (pDrepl )  cannot be removed without loss of replicating ability (Chapter II). To 
determine what portion of the partial ORF l a  sequence is required for DI RNA 
replication, 3 '  terminal in-frame deletions were prepared and tested for replication. 
Deletion constructs were created by recombinant PCR and transcripts of each were 
transfected into helper virus infected human rectal tumor (HR T) cells and assayed by 
Northern analysis for accumulation. Accumulation was regarded as evidence for 
replication. Figure 3-1 illustrates that whereas replication could be demonstrated for 
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8 Oligonucleotide binds to either plus-sense RNA, as indicated by (+), or to minus-sense RNA, as indicated by (-). 
b Underlined bases indicate differences from genomic sequence. 
cNumbers correspond to pDrepl plus-strand sequence, except for TGEV#8(+) and TGEV#Sb(+), in which cases numbers refer to the 
TGEV N gene plus-strand sequence (Kapke and Brian, 1986). Nt numbers in oligonucleotide PGEM3Z24 77(-) correspond to 
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Figure 3-1 . 3 '-terminal, in-frame deletion analysis of288-nt ORF la region 
( continued on next page). 
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Figure 3-1 ( continued). 3 '-terminal, in-frame deletion analysis of 288-nt ORF 
1 a region. A. Schematic map of RN A sequence and potential secondary 
structures present in ORF la. Numbers correspond to start of deletions. B. 
Northern analysis of replication assay. 
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498, it could not be demonstrated for p1 �358-498, p l ali3 19-498, p l ali283-498, 
p 1 �238-498, or p 1 ali2 l 7-498. Thus, a 3 '-terminal deletion of 102-nt but not 14 1 -ht was 
tolerated for replication. · 186 nt of 5 ' -terminal sequence remained in the partial ORF la  
region in a replicating construct. From these experiments it was concluded that the first 
1 86 nt of the partial ORF l a  region contained cis-acting elements for DI RNA 
replication. 
Computer-assisted modeling of RNA secondary structures predicted two higher­
order RNA structures in the 186-nt shortened partial ORF la region. 
With the use of the mfold algorithm developed by Michael Zuker, RNA secondary 
structure can be determined from a single RNA sequence (Zuker et al. , 1 999; Mathews et 
al., 1 999). Mfold RNA secondary structure predictions for the entire 288-nt ORF la  
region of pDrep 1 yielded three stem-loops of significant thermodynamic stability (Fig. 3-
2). These were named stem-loop V, VI, and VII, corresponding in order to previously 
identified RNA stem-loop structures located in the leader and 5 ' -UTR sequences of 
pDrep 1 (Chang et al., 1 994; Chang et al., 1996; Raman, unpublished). 
The 5 '-most RNA stem-loop in the 288-nt ORF l a  region, stem-loop V, is located 
at nt 23 1 to 280 and has a calculated free energy of-1 5.9 kcaVmol (Fig. 3-2). It displays 
some regions of nucleotide sequence conservation with other group II coronaviruses but 
has not investigated further. 
Stem-loop VI, located at nt 308 to 343, has a calculated free energy of-12.3 
kcaVmol. Within it exist three base-paired regions, two bulges, and a terminal loop of 
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Figure 3-2. Computer-assisted (mfold) predictions of RNA secondary structures in the 288-nt partial ORF la  
region and base differences found with other group 2 coronaviruses. Stem-loop IV (mostly in the 5 '-UTR) has been 
shown to exist by enzyme structure probing (Raman, unpublished). Stem-loops V, VI, VII, and VIII have not yet 
been confirmed by structure probing. In-frame methionine codons are boxed. Nucleotides without superscripts are 
those found in all three strains ofMHV (i.e., MHV-A59, MHV-JHM, and MHV-2). Superscript identities are as 
follows: a, MHV-A59; j, MHV-JHM; 2, MHV-2; e, equine coronavirus; o, HCoV-OC43; h, HEV. 
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by mfold predictions. Stem-loop VI for human enteric coronavirus-4408, human 
respiratory coronavirus-OC43, and porcine hemagglutirtating encephalomyelitis virus . . 
were the same size as that for BCo V (36-nt), whereas the predicted homologue in mouse 
hepatitis virus A59 and equine coronaviruses were smaller (1 7-nt and 1 5-nt, 
respectively). Interestingly, the terminal loop among the group II coronaviruses displays 
much nucleotide sequence variation. The highest nucleotide sequence conservation is 
found among nucleotides making up the base of stem VI (Fig. 3-2). 
Stem-loop VII is located at nts 378 through 446 and has a calculated free energy 
of -26.5 kcal/mol (Fig. 3-2). Of the three stem-loops, stem-loop VII is overall the most 
highly conserved in sequence and structure among the group II coronaviruses. Within its 
69 nts there are found six base paired regions, 5 bulges, and a 4-nt terminal loop (Fig. 3-
2). Interestingly, none of the terminal loops are conserved in sequence among the group 
II coronaviruses. Inasmuch as three-quarters of stem-loop VII maps within the 3 ' -
terminal 1 02 nts that can be deleted without loss of DI RNA replication. No further 
studies were carried out on stem-loop VII. Thus, from the results of deletion analyses it 
was concluded that cis-acting features for replication of pDrep 1 RNA may reside in stem­
loops V and VI, or some other yet to be determined structure. 
Functional analysis of stem-loop VI demonstrated a cis-acting role in DI RNA 
replication. 
To test the role of stem-loop VI in DI RNA replication, base substitutions were 
introduced that were predicted to disrupt the positive-sense stem-loop structure while 
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preserving the wild-type amino acid sequence. For this, mutations were necessarily 
restricted to the third nucleotide, or "wobble'' position, in the codons. In construct pLeft 
VI, the base substitutions were made in the left side of stem VI and were 315G➔ A and 
318G➔C (Fig. 3-3). Structure predictions by the mfold algorithm indicated that these 
mutations together would severely disrupt base pairing and lead to a disruption of the 
entire stem structure. When transcripts of pLeft VI were tested in a replication assay, no 
replication was observed (Fig. 3-3). Additionally, no DI RNA accumulation was 
detected at viral passages 1 or 2. Thus, DI RNA replication was impaired when the 
structure of stem-loop VI was disrupted by mutations in the left arm. In construct pRight 
VI, the base substitutions 333C➔G and 336C➔T were made which were predicted to 
disrupt stem .structure but at the same time maintain the wild-type amino acid sequence. 
As with, pLeft VI, no replication was observed as noted by the absence of accumulation 
at 24 and 48 hpt and after viral passages 1 and 2 (Fig. 3-3). 
By combining the mutations in pLeft VI and pRight VI, mutant pLtRt VI was 
created in which it was predicted by the mfold program that the stem of stem-loop VI 
would be restored. The wild-type amino acid sequence was maintained in pLtRt VI. 
When transcripts of pLtRt VI were tested for replication, accumulation was observed at 
24 and 48 hpt, but less than at wild-type levels (Fig. 3-3). At viral passages 1 and 2, 
replication of pLtRt VI appeared robust. From these results it was concluded that stem­
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Figure 3-3 .  Mutations in BCo V stem-loop VI and effect on replication. A. Nucleotide 
sequence within stem-loop VI with mutations indicated by arrows. Mutant pLtRt VI 
contains combined changes of pLeft VI and pRight VI. B. Northern analysis of mutant 
constructs. 
DISCUSSION 
In experiments presented here we show evidence for a novel RNA cis-acting 
replication element mapping within the first 186-nt region of ORF 1 a. We demonstrate 
that it is required for BCoV DI RNA replication. First, a deletion analysis that 
maintained a single contiguous ORF in every construct revealed that only the 5 '-terminal 
186-nt of the 288-nt ORF la  region is needed for DI RNA replication. Second, 
computer-assisted RNA folding analysis by the mfold algorithm predicted formation of a 
phylogenetically conserved stem-loop VI located at nts 308-343. Third, mutations 
predicted to disrupt the stem of stem-loop VI while at the same time maintaining the 
wild-type amino acid sequence destroyed replicating ability. Compensatory mutations 
. that were predicted to restore secondary structure also restored replicating ability. This is 
the first evidence of a higher-order cis-acting replication element mapping within the 
coding region of a coronavirus. 
Cis-acting, higher-order RNA structural elements mapping within a protein­
coding sequence are a relatively recently discovered phenomenon in eukaryotic plus­
strand RNA viruses. To date, cis-acting RNA elements with these properties have been 
described in only the picornaviruses HRV-14, Theiler's virus, mengo virus, and 
poliovirus. In the prokaryotic bacteriophage QP a structure having these properties has 
also been described (Barrera et al., 1993; Miranda et al. , 1997). 
How might these cis-acting elements function? (1) In bacteriophage QP the 
internal ere has been demonstrated to be the nucleation site for the assembly of the 
replicase complex. A tertiary RNA structure brings together the S-site and the M-site to 
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create a protein-binding domain for its viral RNA polymerase and host cell proteins. 
Thus, RNA plus-strand template recognition for minus-strand synthesis is achieved 
(Miranda et al. , 1997). (2) In the three picomavirus genera, rhinovirus, cardiovirus,- and 
enterovirus, all three higher order cis-acting replication elements (ere) form on the 
positive-strand RNA. Additionally, human rhinovirus type 14 (HRV- 14) and poliovirus 
ere mutants that result in loss of RNA replication occur because of impaired initiation of 
minus-strand synthesis. Since they are on the genome-sense strand, these RNA structures 
are hypothesized to function as recognition sites or binding sites for viral and/or cellular 
proteins involved in RNA replication. Consequently, functional loss of these ere 
elements results in loss of minus-strand synthesis (McKnight and Lemon, 1 998) 
(Goodfellow et al. , 2000) (Lobert et al., 1999). Further experimentation is needed to 
determine how stem-loop VI in BCo V DI RNA functions mechanistically ( discussed in 
Chapter IV). 
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CHAPTER IV. 
CONCLUSIONS AND FUTURE DIRECTIONS 
This study describes the discovery of two cis-acting elements mapping within the 
288-nt partial ORF 1 a region in BCo V DI RNA replication. Two broad categories of 
analysis are proposed for the future study. The· first is a more precise characterization of 
the respective elements described in Chapters II and III and an analysis of stem-loop V 
that has not yet been characterized at all. The work in this study was largely one of 
documenting of the existence of the cis-acting protein and RNA stem-loop VI. The 
second category is a determination of the actual roles of these elements in RNA 
replication. 
Regarding the cis-acting ORF la  polypeptide, the following should be done. 1 )  It 
should be confirmed that the ORF 1 a frameshift mutations have not introduced undesired 
stop codons. This could be done by in vitro translation analyses using the mutant 
transcripts and the methods described in Chapter II. 2) The cis-acting protein should be 
compared with known functional protein motifs and those motifs associated with post­
translational modifications. This could be done by computer searches. 3) The proteins 
should be localized in infected cells. Recent biochemical and fluorescent microscope 
studies have proven successful in determining where the various cleavage protein 
products of mouse hepatitis coronavirus ORF 1 a and 1 b polyprotein localize in infected 
cells. These results provide clues as to where and how the proteins might function. 
MHV p28, the full-length homologue of the partial ORF la  polypeptide located in 
pDrepl ,  has been shown to localize with replication complexes and sites of RNA 
52 
synthesis (Denison et al. , 1999; Bost et al. 2000). More information about the 
localization of the partial ORF l a-N fusion encoded by BCoV pDrepl might provide 
insight into its function. 
Regarding the cis-acting stem-loop VI, precisely what features in its structure are 
required for its function? This question requires a more rigorous characterization of its 
structure. For this, enzyme structure probing in which specific single-stranded and 
double-stranded RNases are used to map base paired and looped regions should be done. 
While mfold predictions and phylogenic comparisons suggests the presence of stem-loop 
VI, biochemical data proving its actual structure would aid in the interpretation our 
mutagenesis data presented in Chapter Ill. Additionally, enzyme probing would confirm 
or rule out the existence of stem-loop VI on positive-sense RNA. 
Further characterization of stem-loop VI would also address questions regarding 
its dependence on position for function. Studies with cis-acting replication elements (ere) 
in poliovirus and human rhinovirus- 14 (HRV-14) genomes demonstrate that these stem­
loop structures can function in a position-independent manner within their respective 
coding regions (McKnight and Lemon, 1998; Goodfellow et al. , 2000). Also, in . 
poliovirus it was demonstrated with replicons containing a single, mutated, non­
functional ere that RNA replication could be restored upon addition of a second, wild­
type internal ere (Goodfellow et al., 2000). Similar questions should be addressed with 
stem-loop VI ofpDrep l .  Can stem-loop VI function in a position-independent manner as 
well? Are there spatial constraints on the position of stem-loop VI requiring a specific 
distance from either the 5 '  or 3 ' -UTR? Might a mutated, nonfunctional stem-loop VI in 
pDrepl be functionally compensated by the addition of a second, wild-type stem-loop VI 
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at a different position? These questions can be addressed with the methods employed in 
this study. 
Regarding the function of stem-loop VI, several aspects should be investigated. 
First, it should be determined at which stage in RNA replication stem-loop VI is required. 
It has been shown with HRV- 14 and poliovirus ere elements that they are involved in the 
initiation of minus-strand RNA synthesis (McKnight and Lemon, 1998; Goodfellow et 
al. , 2000). For this, the ribonuclease protection assay was used for detection of newly­
synthesized minus-strand RNA (McKnight and Lemon, 1998; Goodfellow et al. , 2000) 
and could be similarly employed for investigating whether BCoV stem-loop VI mutations 
affect minus or plus-strand RNA synthesis. Second, the electrophoretic mobility shift 
assay should be used to determine whether a viral or cellular protein(s) binds to stem­
loop VI. The mutants studied in the replication assay above could be used in the binding 
assay. It is predicted that protein that would bind to the wild-type structure would not 
bind to the mutated structure. Third, the potential for long range, tertiary interactions of 
stem-loop VI with other RNA structures should be investigated. Fourth, it should be 
determined whether the phylogenetic conservation in structure of stem-loop VI in group 2 
coronaviruses reflects a conservation in function. It was demonstrated with the related 
Theiler' s and mengo enteroviruses that internal ere structures could be functionally 
exchanged in chimeric molecules. However, the HRV-14 internal ere could not be 
functionally exchanged with Theiler' s  virus (Lobert et al. , 1999). Can BCoV stem-loop 
VI be functionally exchanged with homologous regions in other group 1 ,  2, or 3 
coronaviruses? Synthesis of chimeric molecules tested in the in vivo replication assay 
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